Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
British Journal of Cancer
|
December 29, 2021
Immune biomarkers and response to checkpoint inhibition of BRAF<sup>V600</sup> and BRAF non-V600 altered lung cancers
Yonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, et al.
Cancer
|
August 31, 2019
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
Michael Offin, Daniel Feldman, Ai Ni, et al.
Cancer Research
|
November 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2025
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report
Gregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T Li, Ronglai Shen, Darren Buonocore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
Jason C Chang, Michael Offin, Christina Falcon, et al.
JCO Precision Oncology
|
September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Journal of Hematology & Oncology
|
October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Cancer Discovery
|
August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
Lars D Engstrom, Ruth Aranda, Laura Waters, et al.
Cancer Cell
|
October 15, 2021
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Joseph M Chan, Álvaro Quintanal-Villalonga, Vianne Ran Gao, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
British Journal of Cancer
|
December 29, 2021
Immune biomarkers and response to checkpoint inhibition of BRAF<sup>V600</sup> and BRAF non-V600 altered lung cancers
Yonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, et al.
Cancer
|
August 31, 2019
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
Michael Offin, Daniel Feldman, Ai Ni, et al.
Cancer Research
|
November 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2025
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report
Gregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T Li, Ronglai Shen, Darren Buonocore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
Jason C Chang, Michael Offin, Christina Falcon, et al.
JCO Precision Oncology
|
September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Journal of Hematology & Oncology
|
October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Cancer Discovery
|
August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
Lars D Engstrom, Ruth Aranda, Laura Waters, et al.
Cancer Cell
|
October 15, 2021
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Joseph M Chan, Álvaro Quintanal-Villalonga, Vianne Ran Gao, et al.
Page
of 9